RAI2 Inhibitors
RAI2 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of the RAI2 (Retinoic Acid-Induced 2) protein. RAI2 is a protein that plays a significant role in various cellular processes, including gene regulation, cellular differentiation, and development, particularly in the context of retinoic acid signaling. Retinoic acid, a derivative of vitamin A, is known to influence the expression of genes critical for cell growth and differentiation, and RAI2 is thought to be one of the downstream effectors of this pathway. RAI2 functions in gene transcription regulation by interacting with other proteins or directly binding to specific DNA sequences, modulating the expression of target genes. Inhibitors of RAI2 work by disrupting these interactions, blocking the protein's ability to influence gene transcription, and preventing it from carrying out its regulatory role in cellular processes.
The inhibition of RAI2 can lead to significant alterations in gene expression, affecting cellular differentiation, growth, and other vital processes influenced by retinoic acid signaling. By preventing RAI2 from interacting with its partners or binding to DNA, these inhibitors can interfere with the transcription of genes that are essential for proper cell function. Researchers use RAI2 inhibitors to explore the protein's specific role in retinoic acid-induced pathways, seeking to understand how RAI2 contributes to regulating gene expression and maintaining cellular homeostasis. These inhibitors are valuable tools for studying the broader network of transcriptional regulators that operate downstream of retinoic acid signaling. By blocking RAI2 activity, scientists can better understand how this protein fits into the larger framework of transcriptional regulation and how its modulation impacts various physiological processes. Additionally, studying RAI2 inhibitors helps provide insights into the complex regulatory mechanisms that govern cellular responses to external signals and the role of retinoic acid in controlling gene expression and cellular differentiation.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid could downregulate RAI2 by binding to retinoic acid receptors, which may lead to a decrease in transcriptional activation of the RAI2 gene in a context-dependent manner, particularly in tissues where retinoid signaling plays a crucial role in cellular differentiation and development. | ||||||
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $75.00 $120.00 | 8 | |
By activating retinoid receptors, 13-cis-Retinoic acid may decrease RAI2 transcription. This retinoid receptor activation could lead to targeted suppression of RAI2 gene expression, as these receptors are involved in transcriptional control of numerous genes during development. | ||||||
Acitretin | 55079-83-9 | sc-210754 | 25 mg | $151.00 | 1 | |
Acitretin could reduce RAI2 expression by engaging retinoid receptors that control gene expression. The alteration of retinoid receptor activity by acitretin may lead to a specific downregulation of genes like RAI2, which are responsive to changes in retinoid-related signaling. | ||||||
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $55.00 $250.00 | 6 | |
Bexarotene selectively activates retinoid X receptors, which could lead to the targeted downregulation of RAI2. This selective agonism may translate to a specific decrease in RAI2 expression levels in tissues where retinoid X receptor signaling is dominant. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil could indirectly reduce RAI2 expression by inhibiting the synthesis of thymidylate, a necessary component for DNA replication and repair, which could lead to a decrease in the overall transcriptional capacity, including that of the RAI2 gene. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate may lead to reduced expression of RAI2 by decreasing the availability of purine nucleotides, which are critical for DNA and RNA synthesis. By inhibiting dihydrofolate reductase, methotrexate could indirectly suppress the transcription of genes like RAI2. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea could lead to a reduction in RAI2 expression by inhibiting ribonucleotide reductase, resulting in decreased DNA synthesis and potentially leading to a suppression of RAI2 gene transcription as a consequence of impaired DNA replication. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid, by inhibiting histone deacetylases, could lead to a decrease in RAI2 expression by altering the acetylation status of histones near the RAI2 gene, resulting in chromatin compaction and a subsequent reduction in the accessibility of transcriptional machinery to the gene's promoter region. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, could decrease RAI2 expression by promoting the formation of a closed chromatin structure around the RAI2 gene, reducing the efficiency of transcriptional initiation and elongation processes necessary for gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound could decrease RAI2 expression by inducing DNA hypomethylation, which may lead to the repression of gene transcription through the alteration of DNA methylation patterns at the RAI2 gene locus, affecting the binding of transcription factors or co-repressors. | ||||||